VECTICANN
Live / Allowed — Published for opposition (as of 03 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79418894
- Mark type
- Stylized text
- Filed
- 06 Jan 2025
- Published for opposition
- 03 Mar 2026
- Attorney of record
- Scott McCollister
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; transdermal patches for use in the treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; adhesive skin patches for medical purposes, namely, treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; medicated skin preparations, namely skin patches, for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis
Owner
Prosecution history
- 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 26 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Aug 2025 — REFUSAL PROCESSED BY IB
- 06 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 06 Aug 2025 — REFUSAL PROCESSED BY MPU
- 17 Jun 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 16 Jun 2025 — NON-FINAL ACTION WRITTEN
- 16 Jun 2025 — ASSIGNED TO EXAMINER
- 16 Mar 2025 — APPLICATION FILING RECEIPT MAILED